Evidence map›Paper›PMID 30174308›Full record

ArticleCell metabolism2018

Functional Gut Microbiota Remodeling Contributes to the Caloric Restriction-Induced Metabolic Improvements.

Salvatore Fabbiano, Nicolas Suárez-Zamorano, Claire Chevalier, Vladimir Lazarević, Silas Kieser, Dorothée Rigo, Stefano Leo, Christelle Veyrat-Durebex, Nadia Gaïa, Marcello Maresca and 5 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Cell metabolism, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05200468 (Effect of Intermittent Fasting, Caloric Restriction and Ketogenic Diet on Mitochondrial Function and Gut Microbiota in Subjects With Obesity), which is not on this map. Cited by 110 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
110citing papers in PubMed, 3 pooled it
20.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05200468 nacompletednot on this mapstarted 2022, after this paper: background citation

Effect of Intermittent Fasting, Caloric Restriction and Ketogenic Diet on Mitochondrial Function and Gut Microbiota in Subjects With Obesity

TypeinterventionalSponsorInstituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranRan2022 to 2023Enrolled63ConditionsObesityArmsKetogenic diet, Caloric restriction diet, Intermittent fasting 16/8
3 · Its place in the literature

Who cites it

110 citing papers in PubMed, 3 syntheses or guidelines pooled it, 245 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

50 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Salvatore FabbianoDepartment of Cell Physiology and Metabolism, Centre Médical Universitaire, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland; Diabetes Centre, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland.
Nicolas Suárez-ZamoranoDepartment of Cell Physiology and Metabolism, Centre Médical Universitaire, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland; Diabetes Centre, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland.
Claire ChevalierDepartment of Cell Physiology and Metabolism, Centre Médical Universitaire, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland; Diabetes Centre, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland.
Vladimir LazarevićGenomic Research Lab, Division of Infectious Diseases, Geneva University Hospitals, 1211 Geneva, Switzerland.
Silas KieserDepartment of Cell Physiology and Metabolism, Centre Médical Universitaire, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland; Diabetes Centre, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland.
Dorothée RigoDepartment of Cell Physiology and Metabolism, Centre Médical Universitaire, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland; Diabetes Centre, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland.
Stefano LeoGenomic Research Lab, Division of Infectious Diseases, Geneva University Hospitals, 1211 Geneva, Switzerland.
Christelle Veyrat-DurebexDepartment of Cell Physiology and Metabolism, Centre Médical Universitaire, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland; Diabetes Centre, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland.
Nadia GaïaGenomic Research Lab, Division of Infectious Diseases, Geneva University Hospitals, 1211 Geneva, Switzerland.
Marcello MarescaDiscovery Biology, Discovery Sciences, IMED Biotech Unit, AstraZeneca Gothenburg, Mölndal 43183, Sweden.
Doron MerklerDepartment of Pathology and Immunology, Centre Médical Universitaire, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland.
Mercedes Gomez de AgüeroMaurice Müller Laboratories (DKF), Universitätsklinik für Viszerale Chirurgie und Medizin Inselspital, University of Bern, 3010 Bern, Switzerland.
Andrew MacphersonMaurice Müller Laboratories (DKF), Universitätsklinik für Viszerale Chirurgie und Medizin Inselspital, University of Bern, 3010 Bern, Switzerland.
Jacques SchrenzelGenomic Research Lab, Division of Infectious Diseases, Geneva University Hospitals, 1211 Geneva, Switzerland.
Mirko TrajkovskiDepartment of Cell Physiology and Metabolism, Centre Médical Universitaire, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland; Diabetes Centre, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland; Institute of Genetics and Genomics in Geneva, University of Geneva, 1211 Geneva, Switzerland. Electronic address: mirko.trajkovski@unige.ch.
University of Geneva · CHUniversity Hospital of Geneva · CHUniversity of Bern · CHAstraZeneca (Sweden) · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Caloric restriction (CR) stimulates development of functional beige fat and extends healthy lifespan. Here we show that compositional and functional changes in the gut microbiota contribute to a number of CR-induced metabolic improvements and promote fat browning. Mechanistically, these effects are linked to a lower expression of the key bacterial enzymes necessary for the lipid A biosynthesis, a critical lipopolysaccharide (LPS) building component. The decreased LPS dictates the tone of the innate immune response during CR, leading to increased eosinophil infiltration and anti-inflammatory macrophage polarization in fat of the CR animals. Genetic and pharmacological suppression of the LPS-TLR4 pathway or transplantation with Tlr4

Indexed as

Caloric RestrictionGastrointestinal MicrobiomeGastrointestinal TractAdipose Tissue, BeigeAnimalsBacterial ProteinsEosinophilsFatty LiverLipid AMacrophagesMaleMiceMice, Inbred C57BLToll-Like Receptor 4Bacterial ProteinsLipid ATlr4 protein, mouseToll-Like Receptor 4beige fatbrowningcaloric restrictionfatty livergut microbiotainnate immunityinsulin sensitivityTLR4

Identifiers

PMID30174308
PMCPMC6288182
OpenAlexW2889413235

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.